Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 03 Jul 2025 for PMV Pharmaceuticals, Inc., €30k.
Filing timeline
BuySaleDeepika Jalota
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Deepika Jalota: trading record in brief
Deepika Jalota, listed as senior executive, appears in our data through filings on PMV Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 17 August 2021 and 1 July 2025, the trades on record add up to 7 filings.
Every open-market trade on record is a sale: 4 sales worth €149k. The rest of the record consists of 2 share grants and 1 option exercise. 2025 to date brings no purchases and 1 sale.
Most recently, on 3 July 2025, the filings show an open-market sale worth €30k in PMV Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Deepika Jalota
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
33,065 shares@ US$1.064540.3% of flowCommon StockSEC:0001415889-25-019384:0
7,218 shares@ US$1.503618.6% of flowCommon StockSEC:0001415889-24-023313:0
95,555 shares0Common StockSEC:0001209191-24-001999:0
4,104 shares@ US$6.6259.4% of flowCommon StockSEC:0001209191-23-049759:0
34,050 shares0Common StockSEC:0001209191-22-049694:0
2,896 shares@ US$3.5311.8% of flowCommon StockSEC:0001209191-21-052248:0
6 of 6 declarations
